FdaApplication
ANDA 211304
Identifiers
- fda_app_no: ANDA211304
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2021-08-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METARAMINOL BITARTRATE | METARAMINOL BITARTRATE | EQ 10MG BASE/ML | INJECTABLE;INJECTION |
1 product